Chunhui Xu
Lead, AI4Glue platform Degron Therapeutics
Dr. Xu is the AI4GLUE Platform Lead at Degron Therapeutics, where they drive the development of an AI-powered platform for molecular glue discovery.
AI4Glue integrates biological, chemical, structural, and experimental data to support target evaluation, ternary-complex exploration, molecule glue design, hit-to-lead progression, and lead optimization. Their work focuses on building a proprietary Data–Experiment–GlueModel feedback loop to enable more efficient, data-driven, and scalable drug discovery.
Seminars
Wednesday 9th December 2026
AI4GLUE: Closing the Design–Experiment Loop for Predictive Discovery of Molecular Glues
3:00 pm
- Developing AI4GLUE platform to transform complex, multidimensional data into actionable insights for target evaluation and discovery strategy
- Applying AI4GLUE to guide ternary complex exploration, molecular design, activity and selectivity assessment, and lead optimization
- Undergoing experimental validation of AI-generated predictions to refine the platform and accelerate molecular glue therapeutic discovery
